Curative Biotechnology, Inc. (OTCMKTS:CUBT) Short Interest Up 487.9% in April

Curative Biotechnology, Inc. (OTCMKTS:CUBT) was the recipient of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 19,400 shares, an increase of 487.9% from the March 31st total of 3,300 shares. Based on an average daily volume of 678,300 shares, the short-interest ratio is presently 0.0 days.

Curative Biotechnology Trading Up 11.1 %

Shares of CUBT traded up $0.00 during trading hours on Friday, hitting $0.03. 5,000 shares of the stock traded hands, compared to its average volume of 224,864. Curative Biotechnology has a 1-year low of $0.01 and a 1-year high of $0.04. The business has a fifty day moving average of $0.03 and a 200-day moving average of $0.02.

Curative Biotechnology Company Profile

Curative Biotechnology, Inc, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies.